STAT Plus: Gilead faces an antitrust complaint in Brazil over hepatitis C pricing

Several advocacy groups have filed a complaint with antitrust authorities in Brazil, alleging Gilead charged “abusive” prices for a hepatitis C treatment.

Click to view original post